Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-018896
Filing Date
2025-02-12
Accepted
2025-02-12 16:30:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7808
  Complete submission text file 0000950170-25-018896.txt   9525
Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV
Business Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV 31206645500
LSP 7 Cooperative UA (Filed by) CIK: 0001876264 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address BAHNHOFSTRASSE 7 ZUG V8 6300
Business Address BAHNHOFSTRASSE 7 ZUG V8 6300 617-937-2423
Oculis Holding AG (Subject) CIK: 0001953530 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94014 | Film No.: 25615272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)